Infiltrating Bladder Urothelial Carcinoma With Squamous Differentiation
2 clinical trials · Condition
◉ Watch Infiltrating Bladder Urothelial Carcinoma With Squamous Differentiation
| Record | Firm | Date |
|---|---|---|
| Cabozantinib in Combination With Enfortumab Vedotin for Locally Advanced or Metastatic Urothelial Cancer (NCT04878029) | Emory University | 2021-07-23 |
| Pemetrexed and Avelumab in Treating Patients With MTAP-Deficient Metastatic Urothelial Cancer (NCT03744793) | M.D. Anderson Cancer Center | 2019-04-11 |
Track Infiltrating Bladder Urothelial Carcinoma With Squamous Differentiation automatically
Every clearance here is in the API, with alerts when new ones post.